Interferon tau (IFN tau) produces an array of biological effects, including
antiluteolytic, antiviral, antiproliferative and immunomodulatory activiti
es, without the consequent cytotoxicity associated with other type I IFNs,
Four anti-IFN tau monoclonal antibodies (MAbs) have been characterized by d
etermining regional epitopes and observation of their effects on IFN tau bi
nding, antiviral and antiproliferative activity, Using an enzyme-linked imm
unoadsorbent assay (ELISA) developed against six overlapping synthetic pept
ides representing the entire linear sequence of IFN tau, three antibodies,
HL-98, HL-100 and HL-127, were found to react with the carboxy terminal pep
tide, while HL-129 bound the penultimate amino terminal peptide, Binding st
udies indicated that MAbs directed against either region could effectively
inhibit the binding of alkaline phosphatase labeled IFN tau to cells expres
sing type I IFN receptors. While only two of the MAbs significantly reverse
d IFN tau-induced growth inhibition, the antiviral activity of IFN tau was
significantly inhibited by MAbs that bound the amino and carboxy termini, c
onfirming the functional importance of these domains in the binding and sub
sequent activity of IFN tau.